CHARIFSON PAUL S.,CLARK MICHAEL P.,BANDARAGE UPUL K.,BETHIEL RANDY S.,BOYD MICHAEL J.,DAVIES IOANA,DENG HONGBO,DUFFY JOHN P.,FARMER LUC J.,GAO HUAI,GU WENXIN,KENNEDY JOSEPH M.,LEDFORD BRIAN,LEDEBOER M,DE
申请号：
PL12746215
公开号：
PL2739623T3
申请日:
2012.08.01
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A compound is represented by Structural Formula ( I ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
